Ilumivu Company
Founded in 2009, ilumivu provides healthcare decision support applications using the psychology of behavior change, combined with real-time data from smartphones and wearables. With a pedigree in research in multiple disease areas at over 100 leading research universities and health systems, ilumivu delivers just-in-time adaptive interventions based on individualized baselines to improve measurable patient care outcomes. ilumivu supports healthcare research via its digital health SaaS software to monitor patients with multiple health conditions. ilumivu’s digital health platform has been used to monitor numerous diseases and conditions including autism, Alzheimer’s, heart/blood pressure/strokes and cardiovascular diseases, cancer, chronic lung disease including COPD, dementia, epilepsy, mental and behavioral issues, traumatic brain injury, suicidal tendency, and trauma/PTSD. In October 2021, ilumivu acquired heart health app Cardiogram. Cardiogram, founded in 2016, has developed and trained a neural network using millions of cardiovascular data points and records to identify medical conditions such as atrial fibrillation, diabetes, hypertension, and sleep apnea. The Cardiogram mobile app is compatible with Apple iOS and Android smartphones, as well as Apple Watch, WearOS by Google, Fitbit, Garmin, and Samsung wearables. It has been downloaded by more than 2.6 million individuals worldwide.
Industry:
mHealth
Headquarters:
Asheville, North Carolina, United States
Zip:
11-50
Founded Date:
2009-01-01
Employees Number:
11-50
Acquisitions Number:
3
Investors Number:
3
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Series A
Last Funding Type:
stacy.earl@ilumivu.com
Register and Claim Ownership